Pomalidomide for the Treatment of Bleeding in HHT

Clinical trial NCT03910244 · COMPLETED

Trial details

NCT number: NCT03910244
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Telangiectasia, Hereditary Hemorrhagic

Start date: 2019-10-17
Primary completion: 2023-09-08
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.